1. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022) Authors: Maruyama, Dai; Iida, Shinsuke; Machida, Ryunosuke; Kusumoto, Shigeru; Fukuhara, Noriko; Yamauchi, Nobuhiko; Miyazaki, Kana; Yoshimitsu, Makoto; Kuroda, Junya; Tsukamoto, Norifumi; Tsujimura, Hideki; Usuki, Kensuke; Yamauchi, Takahiro; Utsumi, Takahiko; Mizuno, Ishikazu; Takamatsu, Yasushi; Nagata... Journal: Cancer science Issue: Volume 113:Issue 9(2022) Page Start: 3267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. Issue 6 (June 2020) Authors: Sato, Jun; Satouchi, Miyako; Itoh, Shoichi; Okuma, Yusuke; Niho, Seiji; Mizugaki, Hidenori; Murakami, Haruyasu; Fujisaka, Yasuhito; Kozuki, Toshiyuki; Nakamura, Kenichi; Nagasaka, Yukari; Kawasaki, Mamiko; Yamada, Tomoaki; Machida, Ryunosuke; Kuchiba, Aya; Ohe, Yuichiro; Yamamoto, Noboru Journal: Lancet oncology Issue: Volume 21:Issue 6(2020) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗